Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2018

View Archived Issues

Next-generation polymyxins could bring immunotherapy to antibiotics

New hSTING agonists presented as cancer immunotherapy agents

pAAV.CMV.miR204 shows protective effect on photoreceptors in models of inherited retinal disease

Researchers unveil NAXD gene as causative of a neurodegenerative disorder

Compound CAR T cells targeting CLL1 and CD33 in refractory acute myeloid leukemia: phase I results

First human data presented for prostate cancer imaging agent [68Ga]PSMA-093

Embryonic stem cells make helpful heart muscles

New mutations in SLC25A24 gene found to cause Fontaine syndrome

Pivotal phase III trial of Pixuvri in B-cell NHL does not meet primary endpoint

Promising interim data presented from phase I study of oral carbapenem SPR-994

Assembly Biosciences initiates phase IIa studies of ABI-H0731 for HBV

Codexis begins dosing in first-in-human study of CDX-6114 for PKU

Phase III trial of luspatercept in transfusion-dependent beta-thalassemia meets primary endpoint

Intrapulmonary penetration of ETX-2514SUL supports development for respiratory infections

MediciNova announces subgroup analyses from trial of MN-166 in ALS

Catabasis announces plans for phase III trial of edasalonexent in DMD

Bellus Health initiates phase I study of BLU-5937 for the treatment of chronic cough

Matinas collaborates with NINDS to develop HIV therapy based on LNC platform

CPL-207-280CA demonstrates improved glycemic control and safety in vivo

Amgen discovers new beta-secretase inhibitors

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

Pfizer divulges glucagon-like peptide 1 receptor agonists

Cassiopea reports phase III topline results for topical antiandrogen Winlevi for acne

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.